SCHEMBL16802186

SCHEMBL16802186

CC(C)(C)OC(=O)NC(C(=O)OC1CC2CCC(C1)N2)c1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CTSK P43235 3/20 0.48
▸ CTSS P25774 1/20 0.48
▸ CHRNA7 P36544 1/20 0.47
▸ S1PR3 Q99500 1/20 0.41
▸ MMP2 P08253 2/20 0.41
▸ MMP9 P14780 2/20 0.41
▸ ANPEP P15144 2/20 0.41
▸ LTA4H P09960 1/20 0.41
▸ LAP3 P28838 1/20 0.41
▸ NPEPPS P55786 1/20 0.41
▸ ERAP2 Q6P179 1/20 0.41
▸ ERAP1 Q9NZ08 1/20 0.41
▸ LMNA P02545 1/20 0.40
▸ CYP2D6 P10635 1/20 0.40
▸ CYP2C9 P11712 1/20 0.40
▸ HSD17B10 Q99714 1/20 0.40
▸ CHRM2 P08172 2/20 0.40
▸ CHRM1 P11229 2/20 0.40
▸ CHRM4 P08173 1/20 0.40
▸ CHRM5 P08912 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8512023 0.84 LMNA (0.60) CTSKCTSSCHRNA7LMNACYP2D6
SCHEMBL8512028 0.84 LMNA (0.60) CTSKCTSSCHRNA7LMNACYP2D6
SCHEMBL8512022 0.84 LMNA (0.60) CTSKCTSSCHRNA7LMNACYP2D6
SCHEMBL6347304 0.84 MMP2 (0.53) CTSKCTSSS1PR3MMP2MMP9
SCHEMBL27770063 0.84 MMP2 (0.53) CTSKCTSSS1PR3MMP2MMP9
SCHEMBL9290260 0.83 CHRM2 (0.61) CTSKCTSSCHRM2CHRM1CHRM4
Iodide SCHEMBL8509292 0.83 PABPC1 (0.63) CTSKCTSSCHRM2CHRM1CHRM4
SCHEMBL16789062 0.81 CTSS (0.49) CTSKCTSSMMP2MMP9ANPEP
SCHEMBL16789065 0.81 CTSK (0.51) CTSKCTSSS1PR3MMP2MMP9
SCHEMBL30863885 0.80 CTSS (0.48) CTSKCTSSS1PR3MMP2MMP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3077385-B1 HETEROARYL DERIVATIVES FOR THE TREATMENT OF RESPIRATORY DISEASES CHIESI FARM SPA (IT) 2017-10-04 — — EP disclosed
WO-2015082616-A1 HETEROARYL DERIVATIVES FOR THE TREATMENT OF RESPIRATORY DISEASES CHIESI FARMACEUTICI S.P.A. (IT) 2015-06-11 — — WO disclosed
Send feedback